Hematología y Hemoterapia

Resultados: 405
Tipo Título / Nombre Autor(es) Año
Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry Labrador J, Martínez Cuadrón D, Fuente A de la, Rodríguez Veiga R, Serrano J, Tormo M, et al 2020
Biomarker-Driven Phase Ib Clinical Trial of OPB-111077 in Acute Myeloid Leukemia Increases Overall Response Rates Martínez López J, Montesinos P, Martínez Sánchez P, Gorrochategui J, Rojas JL, Prino D, et al 2020
Measurable Residual Disease (MRD) in Elderly Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial Simoes CP, Paiva B, Martínez Cuadron D, Bergua JM, Vives S, Algarra JL, et al 2020
Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia Valhondo I, Hassouneh F..., Bergua JM, Arcos MJ, Bañas H, Casas-Avilés I, et al 2020
Antithrombotic treatment in patients with factor VII deficiency: case reports Moriano B, Bermejo N, Rodríguez A, Espina M, Espina M, Ramos L, et al 2020
Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy Ribera JM, García O, Chapchap EC, Gil C, González-Campos J..., Bergua JM, et al 2020
Acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). study of 61 patients treated with intensive protocols Sitges M, Boluda B, Garrido A, Morgades M, Granada I ..., Bergua J, et al 2020
Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study Rodríguez-Medina C, Martínez-Cuadrón D, Cano I, Gil C, Tormo M..., Bergua-Burgues JM, et al 2020
Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort Borràs N, García-Martínez I, Batlle J, Pérez-Rodríguez A, Parra R..., Bermejo N, et al 2020
Micafungina como profilaxis antifúngica en pacientes hematológicos no trasplantados Villaescusa T, Vázquez L, Bergua JM, García J, Romero A..., Grupo de Infecciones en pacientes hematológicos. Sociedad Andaluza de Hematología y Hemoterapia, et al 2020